204 related articles for article (PubMed ID: 34002327)
1. Incorporating Breastfeeding-Related Variability with Physiologically Based Pharmacokinetic Modeling to Predict Infant Exposure to Maternal Medication Through Breast Milk: a Workflow Applied to Lamotrigine.
Yeung CHT; Ito S; Autmizguine J; Edginton AN
AAPS J; 2021 May; 23(4):70. PubMed ID: 34002327
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine in breast milk and nursing infants: determination of exposure.
Newport DJ; Pennell PB; Calamaras MR; Ritchie JC; Newman M; Knight B; Viguera AC; Liporace J; Stowe ZN
Pediatrics; 2008 Jul; 122(1):e223-31. PubMed ID: 18591203
[TBL] [Abstract][Full Text] [Related]
3. Magnitude of Lamotrigine Exposure Through Breastfeeding.
Kohn E; Dinavitser N; Berlin M; Brandriss N; Bar-Chaim A; Gueta I; Keidar R; Livne A; Stepensky D; Berkovitch M; Masarwi M
Breastfeed Med; 2022 Apr; 17(4):341-348. PubMed ID: 35049332
[No Abstract] [Full Text] [Related]
4. Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions.
Yeung CHT; Autmizguine J; Dalvi P; Denoncourt A; Ito S; Katz P; Rahman M; Theoret Y; Edginton AN
Clin Pharmacokinet; 2024 Mar; 63(3):317-332. PubMed ID: 38278872
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Measurements of Intrauterine and Postnatal Exposure to Lamotrigine.
Paulzen M; Stingl JC; Augustin M; Saßmannshausen H; Franz C; Gründer G; Schoretsanitis G
Clin Pharmacokinet; 2019 Apr; 58(4):535-543. PubMed ID: 30255309
[TBL] [Abstract][Full Text] [Related]
6. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
[TBL] [Abstract][Full Text] [Related]
7. Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for Sotalol.
Pressly MA; Schmidt S; Guinn D; Liu Z; Ceresa C; Samuels S; Madabushi R; Florian J; Fletcher EP
J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S106-S116. PubMed ID: 37317500
[TBL] [Abstract][Full Text] [Related]
8. Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques.
Delaney SR; Malik PRV; Stefan C; Edginton AN; Colantonio DA; Ito S
Clin Pharmacokinet; 2018 Dec; 57(12):1603-1611. PubMed ID: 29651785
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of lamotrigine concentrations in mothers, colostrum, and breastfed newborns during the early postpartum period.
Kacirova I; Grundmann M; Brozmanova H
Biomed Pharmacother; 2022 Jul; 151():113167. PubMed ID: 35617804
[TBL] [Abstract][Full Text] [Related]
10. A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions.
Conner TM; Reed RC; Zhang T
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):389-408. PubMed ID: 30460522
[TBL] [Abstract][Full Text] [Related]
11. A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month.
Kacirova I; Grundmann M; Brozmanova H
Ther Drug Monit; 2019 Jun; 41(3):401-404. PubMed ID: 30688868
[TBL] [Abstract][Full Text] [Related]
12. Quantifying breast milk intake by term and preterm infants for input into paediatric physiologically based pharmacokinetic models.
Yeung CHT; Fong S; Malik PRV; Edginton AN
Matern Child Nutr; 2020 Apr; 16(2):e12938. PubMed ID: 31965755
[TBL] [Abstract][Full Text] [Related]
13. Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model.
Pansari A; Faisal M; Jamei M; Abduljalil K
Biopharm Drug Dispos; 2022 Oct; 43(5):201-212. PubMed ID: 36209366
[TBL] [Abstract][Full Text] [Related]
14. Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic Models.
Tauzin M; Tréluyer JM; Nabbout R; Billette de Villemeur T; Desguerre I; Aboura R; Gana I; Zheng Y; Benaboud S; Bouazza N; Chenevier-Gobeaux C; Freihuber C; Hirt D
J Clin Pharmacol; 2021 May; 61(5):677-687. PubMed ID: 33244764
[TBL] [Abstract][Full Text] [Related]
15. Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study.
Olagunju A; Bolaji O; Amara A; Waitt C; Else L; Adejuyigbe E; Siccardi M; Back D; Khoo S; Owen A
Clin Infect Dis; 2015 Aug; 61(3):453-63. PubMed ID: 25882300
[TBL] [Abstract][Full Text] [Related]
16. When breastfeeding mothers need CNS-acting drugs.
Rubin ET; Lee A; Ito S
Can J Clin Pharmacol; 2004; 11(2):e257-66. PubMed ID: 15591613
[TBL] [Abstract][Full Text] [Related]
17. Severe apnea in an infant exposed to lamotrigine in breast milk.
Nordmo E; Aronsen L; Wasland K; Småbrekke L; Vorren S
Ann Pharmacother; 2009 Nov; 43(11):1893-7. PubMed ID: 19826099
[TBL] [Abstract][Full Text] [Related]
18. Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child.
Madadi P; Ito S
Can Fam Physician; 2010 Nov; 56(11):1132-4. PubMed ID: 21075992
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study on bisphenol A levels and possible exposure history of mother and exclusively breastfed infant pairs.
Sayıcı IU; Simsek Orhon F; Topçu S; Ulukol B; Baskan S
Eur J Pediatr; 2019 Apr; 178(4):541-550. PubMed ID: 30707364
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy.
Birnbaum AK; Meador KJ; Karanam A; Brown C; May RC; Gerard EE; Gedzelman ER; Penovich PE; Kalayjian LA; Cavitt J; Pack AM; Miller JW; Stowe ZN; Pennell PB;
JAMA Neurol; 2020 Apr; 77(4):441-450. PubMed ID: 31886825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
